Where does Q3 Medical Devices Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Q3 Medical Devices Limited ranks #12,181 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Q3 Medical Devices Limited hold?

Q3 Medical Devices Limited holds 25 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is Q3 Medical Devices Limited's Innovation Score?

Q3 Medical Devices Limited has an Innovation Score of 33.4 out of 100 (44th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Q3 Medical Devices Limited's patent grant rate increasing or decreasing?

Q3 Medical Devices Limited's recent grant velocity is +40% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Q3 Medical Devices Limited's patents?

Q3 Medical Devices Limited's patents average 15.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Q3 Medical Devices Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Q3 Medical Devices Limited

Q: What technology areas does Q3 Medical Devices Limited focus on?

Q3 Medical Devices Limited's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 25 patents, ranking #260 of 3,082 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 25 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Q3 ranks #12,181 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 10 technology areas.

#12,181
of 49,997 US assignees by volume: 44th percentile
by Innovation Score (33.4/100): 15.1
avg claims per patent: +40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12181 · Foreign Corporation #12,181 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 25 grants
UPPER-Q #12,181/49,997
PHOTO-FINISH Princeton Identity
CPC-FOCUS A61F · 10 areas
INNOV-THIN 33.4/100
CLAIMS-RICH 15.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Princeton Identity (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Q3’s 33.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.3 pts (34%) Velocity 1.9 pts (6%) Breadth 11.2 pts (33%) Claim depth 9.1 pts (27%)

Qualcomm Incorporated · highest

85
Curiteva · near

33
Novira Therapeutics · near

33
Q3 Medical Devices · this assignee

33
Evga · near

33
Kirintec · near

33
3D Lighting… · lowest

7

What this shows Q3's Innovation Score is 33.4/100 (44th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Q3?

Each dot is one of Q3’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Q3’s own 15.1 claims/patent is ABOVE the 10.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Q3 vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Q3's grants concentrate

Q3 Medical Devices Limited is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2015. By volume, Q3 sits between Princeton Identity and R.Y.L. Inc..

Q3's three-year grant acceleration

Q3 Medical Devices Limited shows 4 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Princeton Identity

25
Princeton Technol…

25
Prospira

25
Pwc Product Sales

25
Quipip

25
Qfix Systems

25
Quip NYC

25
R Y L

25
Q3 Medical Devices ◀

25

What this shows Q3 holds 25 patents at rank #12,178, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Q3

By rank, the assignees closest to #12,178 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Q3's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Q3, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Q3 ranks #260 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (33 here).

Curiteva, Inc. 33 Novira Therapeutics, Inc. 33 Evga Corporation 33 Kirintec Limited 33

Q3's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 44th percentile higher than 44% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Q3 Medical Devices Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	4.0%
2016	3	12.0%
2017	1	4.0%
2018	1	4.0%
2019	4	16.0%
2020	5	20.0%
2021	5	20.0%
2022	1	4.0%
2023	1	4.0%
2024	2	8.0%
2025partial year	1	4.0%

Which technologies does Q3 Medical Devices Limited patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 25

A61B - DIAGNOSIS; SURGERY; Identification 21

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 7

B23K - Soldering OR UNSOLDERING; WELDING; Cladding OR Plating BY Soldering OR WELDING; Cutting BY Applying Heat Locally, e.g. Flame CUTTING; Working BY Laser Beam 4

B05D - Processes FOR Applying Fluent Materials TO Surfaces, IN General 2

D01D - Mechanical Methods OR Apparatus IN THE Manufacture OF Artificial Filaments, Threads, Fibres, Bristles OR Ribbons 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Q3 Medical Devices Limited's patent record in context - here's where to go next.

Q3 Medical Devices Limited's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #12,181 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Q3 Medical Devices Limited against Princeton Identity, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.